254 related articles for article (PubMed ID: 17320923)
1. Critical role of Arg59 in the high-affinity gp120-binding region of CD4 for human immunodeficiency virus type 1 infection.
Fontenot D; Jones JK; Hossain MM; Nehete PN; Vela EM; Dwyer VA; Jagannadha Sastry K
Virology; 2007 Jun; 363(1):69-78. PubMed ID: 17320923
[TBL] [Abstract][Full Text] [Related]
2. CD4 activation of HIV fusion.
Sattentau QJ
Int J Cell Cloning; 1992 Nov; 10(6):323-32. PubMed ID: 1281202
[TBL] [Abstract][Full Text] [Related]
3. Conformational changes of gp120 in epitopes near the CCR5 binding site are induced by CD4 and a CD4 miniprotein mimetic.
Zhang W; Canziani G; Plugariu C; Wyatt R; Sodroski J; Sweet R; Kwong P; Hendrickson W; Chaiken I
Biochemistry; 1999 Jul; 38(29):9405-16. PubMed ID: 10413516
[TBL] [Abstract][Full Text] [Related]
4. Synthetic CD4 exocyclics inhibit binding of human immunodeficiency virus type 1 envelope to CD4 and virus replication in T lymphocytes.
Zhang X; Gaubin M; Briant L; Srikantan V; Murali R; Saragovi U; Weiner D; Devaux C; Autiero M; Piatier-Tonneau D; Greene MI
Nat Biotechnol; 1997 Feb; 15(2):150-4. PubMed ID: 9035140
[TBL] [Abstract][Full Text] [Related]
5. The role of CD4 in HIV binding and entry.
Sattentau QJ; Moore JP
Philos Trans R Soc Lond B Biol Sci; 1993 Oct; 342(1299):59-66. PubMed ID: 7904348
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of human immunodeficiency virus infection by the lectin jacalin and by a derived peptide showing a sequence similarity with gp120.
Favero J; Corbeau P; Nicolas M; Benkirane M; Travé G; Dixon JF; Aucouturier P; Rasheed S; Parker JW; Liautard JP
Eur J Immunol; 1993 Jan; 23(1):179-85. PubMed ID: 8419169
[TBL] [Abstract][Full Text] [Related]
7. Role for the disulfide-bonded region of human immunodeficiency virus type 1 gp41 in receptor-triggered activation of membrane fusion function.
Bellamy-McIntyre AK; Bär S; Ludlow L; Drummer HE; Poumbourios P
Biochem Biophys Res Commun; 2010 Apr; 394(4):904-8. PubMed ID: 20230797
[TBL] [Abstract][Full Text] [Related]
8. Minimal sequence requirements for synthetic peptides derived from the V3 loop of the human immunodeficiency virus type 1 (HIV-1) to enhance HIV-1 binding to cells and infection.
Zanotto C; Calderazzo F; Dettin M; Di Bello C; Autiero M; Guardiola J; Chieco-Bianchi L; De Rossi A
Virology; 1995 Feb; 206(2):807-16. PubMed ID: 7856094
[TBL] [Abstract][Full Text] [Related]
9. NMR studies on the conformation of the CD4 36-59 peptide bound to HIV-1 gp120.
Gizachew D; Moffett DB; Busse SC; Westler WM; Dratz EA; Teintze M
Biochemistry; 1998 Jul; 37(30):10616-25. PubMed ID: 9692951
[TBL] [Abstract][Full Text] [Related]
10. SPC3, a V3 loop-derived synthetic peptide inhibitor of HIV-1 infection, binds to cell surface glycosphingolipids.
Delézay O; Hammache D; Fantini J; Yahi N
Biochemistry; 1996 Dec; 35(49):15663-71. PubMed ID: 8961929
[TBL] [Abstract][Full Text] [Related]
11. Is the V3 loop involved in HIV binding to CD4?
Dettin M; Ferranti P; Scarinci C; Picariello G; Di Bello C
Biochemistry; 2003 Aug; 42(30):9007-12. PubMed ID: 12885233
[TBL] [Abstract][Full Text] [Related]
12. An anti-human immunodeficiency virus multiple antigen peptide encompassing the cleavage region of the env precursor interferes with membrane fusion at a post-CD4 binding step.
Barbouche R; Decroly E; Kieny MP; Fenouillet E
Virology; 2000 Jul; 273(1):169-77. PubMed ID: 10891419
[TBL] [Abstract][Full Text] [Related]
13. Evidence by peptide mapping that the region CD4(81-92) is involved in gp120/CD4 interaction leading to HIV infection and HIV-induced syncytium formation.
Kalyanaraman VS; Rausch DM; Osborne J; Padgett M; Hwang KM; Lifson JD; Eiden LE
J Immunol; 1990 Dec; 145(12):4072-8. PubMed ID: 1701782
[TBL] [Abstract][Full Text] [Related]
14. Identification of N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4.
Zhao Q; Ma L; Jiang S; Lu H; Liu S; He Y; Strick N; Neamati N; Debnath AK
Virology; 2005 Sep; 339(2):213-25. PubMed ID: 15996703
[TBL] [Abstract][Full Text] [Related]
15. Structural basis for the interaction between focal adhesion kinase and CD4.
Garron ML; Arthos J; Guichou JF; McNally J; Cicala C; Arold ST
J Mol Biol; 2008 Feb; 375(5):1320-8. PubMed ID: 18078954
[TBL] [Abstract][Full Text] [Related]
16. Conformational perturbation of the envelope glycoprotein gp120 of human immunodeficiency virus type 1 by soluble CD4 and the lectin succinyl Con A.
Pal R; DeVico A; Rittenhouse S; Sarngadharan MG
Virology; 1993 Jun; 194(2):833-7. PubMed ID: 8503188
[TBL] [Abstract][Full Text] [Related]
17. Effects of CD4 synthetic peptides on HIV type I envelope glycoprotein function.
Repke H; Gabuzda D; Palù G; Emmrich F; Sodroski J
J Immunol; 1992 Sep; 149(5):1809-16. PubMed ID: 1354681
[TBL] [Abstract][Full Text] [Related]
18. Sequential interaction of CD4 and HIV-1 gp120 with a reconstituted membrane patch of ganglioside GM3: implications for the role of glycolipids as potential HIV-1 fusion cofactors.
Hammache D; Yahi N; Piéroni G; Ariasi F; Tamalet C; Fantini J
Biochem Biophys Res Commun; 1998 May; 246(1):117-22. PubMed ID: 9600078
[TBL] [Abstract][Full Text] [Related]
19. Binding of HIV-1 gp120 glycoprotein to silica nanoparticles modified with CD4 glycoprotein and CD4 peptide fragments.
Cheng K; El-Boubbou K; Landry CC
ACS Appl Mater Interfaces; 2012 Jan; 4(1):235-43. PubMed ID: 22117536
[TBL] [Abstract][Full Text] [Related]
20. Atomic insight into the CD4 binding-induced conformational changes in HIV-1 gp120.
Hsu ST; Bonvin AM
Proteins; 2004 May; 55(3):582-93. PubMed ID: 15103622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
